Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats

Journal of Pineal Research

Volumn 44, Issue 4, 2008, Pages 348-357

  Samantaray, Supriti ^a   Sribnick, Eric A ^a   Das, Arabinda ^a   Knaryan, Varduhi H ^b   Matzelle, D Denise ^a   Yallapragada, Anil V ^a   Reiter, Russel J ^c   Ray, Swapan K ^a   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Apoptosis; Calpain; Macrophages; Melatonin; Neurons; Spinal cord injury

Indexed keywords

CALPAIN; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN INDUCTION; RAT; SPINAL CORD INJURY;

ANIMALS; APOPTOSIS; AXONS; CALCIUM; CALPAIN; CASPASE 3; CENTRAL NERVOUS SYSTEM DEPRESSANTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IN SITU NICK-END LABELING; INFLAMMATION; MALE; MELATONIN; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TIME FACTORS;

EID: 38149092274     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00534.x     Document Type: Article

References (66)

1. Spinal cord injury: Facts and figures at a glance. National Science Statistical Center. National Spinal Cord Injury Center, Birmingham, AL 2006.
2. Ray SK, Hogan EL, Banik NL. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev 2003 42 : 169 185.
3. Ray SK, Banik NL. Chaplain and its involvement in the path physiology of CNS injuries and diseases: therapeutic potential of chaplain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2003 2 : 173 189.
4. Dumont RJ, Verma S, Okonkwo DO et al. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol 2001 24 : 265 279.
5. Zimmerman UJ, Boring L, Pak JH et al. The calpain small subunit gene is essential: its inactivation results in embryonic lethality. IUBMB Life 2000 50 : 63 68.
6. Wu HY, Tomizawa K, Oda Y et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 2004 279 : 4929 4940.
7. Blomgren K, Zhu C, Wang X et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 2001 276 : 10191 10198.
8. Wood DE, Thomas A, Devi LA et al. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 1998 17 : 1069 1078.
9. Ray SK, Neuberger TJ, Deadwyler G et al. Calpain and calpastatin expression in primary oligodendrocyte culture: preferential localization of membrane calpain in cell processes. J Neurosci Res 2002 70 : 561 569.
10. Nath R, Raser KJ, Stafford D et al. Non-erythroid α-spectrin breakdown by calpain and interleukin-1β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J 1996 3 : 683 690.
11. Sribnick EA, Ray SK, Banik NL. Estrogen prevents glutamate-induced apoptosis in c6 glioma cells by a receptor-mediated mechanism. Neuroscience 2006 137 : 197 209.
12. Das A, Sribnick EA, Wingrave JM et al. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res 2005 81 : 551 562.
13. Mccracken E, Hunter AJ, Patel S et al. Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J Neurotrauma 1999 16 : 749 761.
14. Ray SK, Wilford GG, Crosby CV et al. Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res 1999 829 : 18 27.
15. Ray SK, Matzelle DD, Wilford GG et al. Cell death in spinal cord injury (SCI) requires de novo protein synthesis: calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra. Ann N Y Acad Sci 2001 939 : 436 449.
16. Bracken MB, Shepard MJ, Collins WF JR. et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the Second National Acute Spinal Cord Injury Study. J Neurosurg 1992 76 : 23 31.
17. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000 93 : 1 7.
18. Tan D-X, Chen L-D, Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J 1993 1 : 57 60.
19. Allegra M, Reiter RJ, Tan DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003 34 : 1 10.
20. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001 34 : 237 256.
21. Cuzzocrea S, Reiter RJ. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2002 2 : 153 165.
22. Reiter RJ, Burkhardt S, Cabrera J, Garcia JJ. Beneficial neurobiological effects of melatonin under conditions of increased oxidative stress. Curr Med Chem - Central Nervous System Agents 2002 2 : 45 58.
23. Reiter RJ, Tan DX, Leon J et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood, NJ) 2005 230 : 104 117.
24. Beni SM, Kohen R, Reiter RJ et al. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-κB and AP-1. FASEB J 2004 18 : 149 151.
25. Erten SF, Kocak A, Ozdemir I et al. Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord 2003 41 : 533 538.
26. Genovese T, Mazzon E, Muia C et al. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res 2005 38 : 198 208.
27. Fujimoto T, Nakamura T, Ikeda T, Takagi K. Potent protective effects of melatonin on experimental spinal cord injury. Spine 2000 25 : 769 775.
28. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem 2002 2 : 167 179.
29. Maldonado MD, Murillo-Cabezas F, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2006 42 : 1 11.
30. Jou MJ, Peng TI, Reiter RJ et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004 37 : 55 70.
31. Lin AM, Fang SF, Chao PL, Yang CH. Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of α-synuclein. J Pineal Res 2007 43 : 163 171.
32. Radogna F, Paternoster L, Albertini MC et al. Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells. J Pineal Res 2007 43 : 154 162.
33. Yallapragada AV, Stucki BL, Sribnick EA, et al. Melatonin attenuated calpain expression and neuronal death in the lesion and caudal penumbra following spinal cord injury in rats. Program No. 108.6. 2004 Abstract Viewer/Itinerary Planner. Society for Neuroscience, 2004, Washington, DC Online.
34. Perot PL, Jr. Lee WA, Hsu CY et al. Therapeutic model for experimental spinal cord injury in the rat: I. Mortality and motor deficit. Cent Nerv Syst Trauma 1987 4 : 149 159.
35. Chakrabarti AK, Yoshida Y, Powers JM et al. Calcium-activated neutral proteinase in rat brain myelin and subcellular fractions. J Neurosci Res 1988 20 : 351 358.
36. Ray SK, Schaecher KE, Shields DC et al. Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc 2000 5 : 305 311.
37. Samantaray S, Knaryan V, Banik NL. Parkinsonian neurotoxin rotenone activated calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 2007 146 : 741 755.
38. Sur P, Sribnick EA, Wingrave JM et al. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 2003 971 : 178 188.
39. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 : 680 685.
40. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979 76 : 4350 4354.
41. Shields DC, Schaecher KE, Hogan EL, Banik NL. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res 2000 61 : 146 150.
42. Wingrave JM, Schaecher KE, Sribnick EA et al. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res 2003 73 : 95 104.
43. Li Z, Hogan EL, Banik NL. Role of calpain in spinal cord injury: Increased mcalpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int 1995 27 : 425 432.
44. Banik NL, Shields DC, Ray SK, Hogan EL. The pathophysiological role of calpain in spinal cord injury. In : The pharmacology and toxicology of calcium dependent proteases. Wang KKW, Yuen P-W, eds. Taylor and Francis Publishers, Washington D.C., 1999 pp. 211 227.
45. Gomes-Leal W, Corkill DJ, Freire MA et al. Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Exp Neurol 2004 190 : 456 467.
46. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998 3 : 359 384.
47. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
48. Tan DX, Reiter RJ, Manchester LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002 2 : 181 197.
49. Chera B, Schaecher KE, Rocchini A et al. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Brain Res 2004 1006 : 150 156.
50. Crocker SJ, Smith PD, Jackson-Lewis V et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 2003 23 : 4081 4091.
51. Posmantur R, Hayes RL, Dixon CE, Taft WC. Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury. J Neurotrauma 1994 11 : 533 545.
52. Saatman KE, Murai H, Bartus RT et al. Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci USA 1996 93 : 3428 3433.
53. Sribnick EA, Wingrave JM, Matzelle DD et al. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res 2005 82 : 283 293.
54. Raynaud F, Marcilhac A. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FASEB J 2006 273 : 3437 3443.
55. Sribnick EA, Matzelle DD, Ray SK, Banik NL. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J Neurosci Res 2006 84 : 1064 1075.
56. Saija A, Tomaino A, Trombetta D et al. Interaction of melatonin with model membranes and possible implications in its photoprotective activity. Eur J Pharm Biopharm 2002 53 : 209 215.
57. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999 49 : 377 391.
58. Cayli SR, Kocak A, Yilmaz U et al. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J 2004 13 : 724 732.
59. Kaptanoglu E, Tuncel M, Palaoglu S et al. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg 2000 93 : 77 84.
60. Genovese T, Mazzon E, Crisafulli C et al. Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J Pineal Res 2007 43 : 140 153.
61. Mccutcheon EP, Selassie AW, Gu JK, Pickelsimer EE. Acute traumatic spinal cord injury, 1993-2000a population-based assessment of methylprednisolone administration and hospitalization. J Trauma 2004 56 : 1076 1083.
62. Olivieri G, Otten U, Meier F et al. β-Amyloid modulates tyrosine kinase B receptor expression in SH-SY5Y neuroblastoma cells: influence of the antioxidant melatonin. Neuroscience 2003 120 : 659 665.
63. Lahiri DK, Chen D, Lahiri P et al. Melatonin, metals, and gene expression: Implications in aging and neurodegenerative disorders. Ann N Y Acad Sci 2004 1035 : 216 230.
64. Leon J, Acuna-Castroviejo D, Sainz R et al. Melatonin and mitochondrial function. Life Sci 2004 75 : 765 790.
65. Reiter RJ, Tan DX, Manchester LC, El-Sawi MR. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci 2002 959 : 238 250.
66. Liu JB, Tang TS, Yang HL, Xiao DS. Anti-oxidation of melatonin against spinal cord injury in rats. Chinese Med J 2004 117 : 571 575.